Federal Health Minister Syed Mustafa Kamal led a high‑level meeting on July 9, 2025, with the Drug Regulatory Authority of Pakistan (DRAP) to accelerate reforms in medical device regulations. The meeting focused on resolving registration delays, fast‑tracking import approval, and encouraging local manufacturing of essential healthcare equipment.

Attendees included DRAP leadership, stakeholders from the Healthcare Devices Association of Pakistan, and representatives from the Commerce Division. Industry experts advocated for adopting global standards like CE and FDA certifications and reducing bureaucratic hurdles to make it easier for manufacturers to enter the market with items ranging from protective masks to diagnostic devices.

The Minister emphasized the need for swift administrative measures to clear regulatory backlogs and ensure essential medical devices reach hospitals and clinics without delay. He pledged that steps would be implemented within days to address long-pending registration demands.

Industry leaders welcomed the proposed reforms but stressed that incentives such as tax rebates and regulatory clarity are essential to encourage domestic manufacturing. They also recommended a phased rollout, starting with low-risk devices and scaling up over time a strategy the government appeared to support.